{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:32:30Z","timestamp":1792755150825,"version":"4.5.0"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Interstitial lung disease (ILD) is one of the most serious lung complications of connective tissue disease (CTD). The application of proteomics in the past decade has revealed that various proteins are involved in the pathogenesis of each subtype of CTD-ILD through different pathways, providing novel ideas to study pathological mechanisms and clinical biomarkers. On this basis, a multidimensional diagnosis or prediction model is established. This paper reviews the results of proteomic detection of different subtypes of CTD-ILD and discusses the role of some differentially expressed proteins in the development of pulmonary fibrosis and their potential clinical applications.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1146904","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T01:30:41Z","timestamp":1680053441000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Proteomics: Potential techniques for discovering the pathogenesis of connective tissue diseases-interstitial lung disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Yinlan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"206ra139","DOI":"10.1126\/scitranslmed.3006998","article-title":"Bpifb1 is a lung-specific autoantigen associated with interstitial lung disease","volume":"5","author":"Shum","year":"2013","journal-title":"Sci Trans Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(20)30452-5","article-title":"Home monitoring for patients with ild and the covid-19 pandemic","volume":"8","author":"Nakshbandi","year":"2020","journal-title":"Lancet Respir Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-0741","article-title":"Diagnosis and treatment of connective tissue disease-associated interstitial lung disease","volume":"143","author":"Vij","year":"2013","journal-title":"Chest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"Cd010908","DOI":"10.1002\/14651858.CD010908.pub2","article-title":"Cyclophosphamide for connective tissue disease-associated interstitial lung disease","volume":"1","author":"Barnes","year":"2018","journal-title":"Cochrane Database systematic Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.berh.2016.04.006","article-title":"Connective tissue disease-related interstitial lung disease","volume":"30","author":"Demoruelle","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201607-1484\u00b0C","article-title":"Interstitial lung disease in india. the results of a prospective registry","volume":"195","author":"Singh","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann rheumatic Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201004-0622\u00b0C","article-title":"Rheumatoid arthritis-interstitial lung disease-associated mortality","volume":"183","author":"Olson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2019.05.004","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"40","author":"Long","year":"2019","journal-title":"Clinics chest Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61737-960-4_13","article-title":"Gel-based and gel-free proteomic technologies","volume":"702","author":"Scherp","year":"2011","journal-title":"Methods Mol Biol (Clifton NJ)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmw167","article-title":"Proteomics: Technologies and their applications","volume":"55","author":"Aslam","year":"2017","journal-title":"J chromatographic Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"New Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/art.40574","article-title":"The lung in rheumatoid arthritis: Focus on interstitial lung disease","volume":"70","author":"Spagnolo","year":"2018","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1378\/chest.13-1394","article-title":"Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis","volume":"146","author":"Doyle","year":"2014","journal-title":"Chest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.171315","article-title":"Rheumatoid arthritis-interstitial lung disease in the united states: Prevalence, incidence, and healthcare costs and mortality","volume":"46","author":"Raimundo","year":"2019","journal-title":"J Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2021-217822","article-title":"Serum proteomic profiling of rheumatoid arthritis-interstitial lung disease with a comparison to idiopathic pulmonary fibrosis","author":"Wu","year":"2022","journal-title":"Thorax"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-010-0116-z","article-title":"Interstitial lung disease in rheumatoid arthritis","volume":"12","author":"Ascherman","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.alit.2015.08.002","article-title":"Fragmented gelsolins are increased in rheumatoid arthritis-associated interstitial lung disease with usual interstitial pneumonia pattern","volume":"65","author":"Suhara","year":"2016","journal-title":"Allergology Int"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.107946","article-title":"Gelsolin expression is necessary for the development of modeled pulmonary inflammation and fibrosis","volume":"64","author":"Oikonomou","year":"2009","journal-title":"Thorax"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.609773","article-title":"Establishing classification tree models in rheumatoid arthritis using combination of matrix-assisted laser Desorption\/Ionization time-of-Flight mass spectrometry and magnetic beads","volume":"8","author":"Ma","year":"2021","journal-title":"Front Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12931-019-0980-7","article-title":"Interstitial lung disease associated with systemic sclerosis (Ssc-ild)","volume":"20","author":"Cottin","year":"2019","journal-title":"Respir Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01541-5","article-title":"Economic burden and management of systemic sclerosis-associated interstitial lung disease in 8 European countries: The buildup Delphi consensus study","volume":"38","author":"Davidsen","year":"2021","journal-title":"Adv Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: A study from the eular scleroderma trials and research (Eustar) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann rheumatic Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200301007","article-title":"Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis","volume":"5","author":"Rottoli","year":"2005","journal-title":"Proteomics"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07438.x","article-title":"Effect of small interfering rna on the expression of connective tissue growth factor and type I and iii collagen in skin fibroblasts of patients with systemic sclerosis","volume":"155","author":"Xiao","year":"2006","journal-title":"Br J Dermatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/genes9120588","article-title":"Systems analysis of transcriptomic and proteomic profiles identifies novel regulation of fibrotic programs by mirnas in pulmonary fibrosis fibroblasts","volume":"9","author":"Mullenbrock","year":"2018","journal-title":"Genes"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key223","article-title":"Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100a6 and 14-3-3\u03f5 as potential biomarkers","volume":"58","author":"Landi","year":"2019","journal-title":"Rheumatol (Oxford England)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jprot.2013.03.006","article-title":"Toward a functional proteomics approach to the comprehension of idiopathic pulmonary fibrosis, sarcoidosis, systemic sclerosis and pulmonary langerhans cell histiocytosis","volume":"83","author":"Landi","year":"2013","journal-title":"J Proteomics"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1172\/jci144016","article-title":"Tnfr2\/14-3-3\u03f5 signaling complex instructs macrophage plasticity in inflammation and autoimmunity","volume":"131","author":"Fu","year":"2021","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158080","article-title":"Mitochondrial oxidative stress induces cardiac fibrosis in obese rats through modulation of transthyretin","volume":"23","author":"Mart\u00ednez-Mart\u00ednez","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/art.41418","article-title":"Bioactive plasma mitochondrial DNA is associated with disease progression in scleroderma-associated interstitial lung disease","volume":"72","author":"Ryu","year":"2020","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-7-11","article-title":"Functional and phenotypical comparison of myofibroblasts derived from biopsies and bronchoalveolar lavage in mild asthma and scleroderma","volume":"7","author":"Larsen","year":"2006","journal-title":"Respir Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067655","article-title":"A polymorphism in the ctgf promoter region associated with systemic sclerosis","volume":"357","author":"Fonseca","year":"2007","journal-title":"New Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3722-5","article-title":"The status of pulmonary fibrosis in systemic sclerosis is associated with Irf5, Stat4, Irak1, and ctgf polymorphisms","volume":"37","author":"Zhao","year":"2017","journal-title":"Rheumatol Int"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00530.2007","article-title":"Proteomic analysis of ctgf-activated lung fibroblasts: Identification of Iqgap1 as a key player in lung fibroblast migration","volume":"295","author":"Bogatkevich","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-205013","article-title":"Proteomic analysis of plasma identifies the toll-like receptor agonists S100a8\/A9 as a novel possible marker for systemic sclerosis phenotype","volume":"73","author":"van Bon","year":"2014","journal-title":"Ann rheumatic Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"R160","DOI":"10.1186\/ar2067","article-title":"Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis","volume":"8","author":"Fietta","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and Cxcl4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"New Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.10-OA-0176","article-title":"Proteome analysis of bronchoalveolar lavage fluid in lung fibrosis associated with systemic sclerosis","volume":"59","author":"Shirahama","year":"2010","journal-title":"Allergology Int Off J Japanese Soc Allergology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.9b00713","article-title":"Evaluation of glutathione s-transferase inhibition effects on idiopathic pulmonary fibrosis therapy with a near-infrared fluorescent probe in cell and mice models","volume":"91","author":"He","year":"2019","journal-title":"Analytical Chem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/s0378-4274(99)00230-1","article-title":"Glutathione s-transferase: Genetics and role in toxicology","author":"Strange","year":"2000","journal-title":"Toxicol Lett"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201204-0754\u00b0C","article-title":"Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation","volume":"186","author":"Booth","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/art.39575","article-title":"Netrin-1 regulates fibrocyte accumulation in the decellularized fibrotic sclerodermatous lung microenvironment and in bleomycin-induced pulmonary fibrosis","volume":"68","author":"Sun","year":"2016","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106581","article-title":"Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay","volume":"187","author":"Jee","year":"2021","journal-title":"Respir Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"17958","DOI":"10.1038\/s41598-018-36395-z","article-title":"Patients with anti-Jo1 antibodies display a characteristic igg fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies","volume":"8","author":"Fernandes-Cerqueira","year":"2018","journal-title":"Sci Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.09.007","article-title":"Interstitial lung disease outcomes by high-resolution computed tomography (Hrct) in anti-Jo1 antibody-positive polymyositis patients: A single centre study and review of the literature","volume":"11","author":"Ingegnoli","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2018.1120","article-title":"Increased serum matrix metalloproteinase-9 levels are associated with anti-Jo1 but not anti-Mda5 in myositis patients","volume":"10","author":"Liu","year":"2019","journal-title":"Aging Dis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1021\/pr800943t","article-title":"2-de and lc-Ms\/Ms for a comparative proteomic analysis of balf from subjects with different subsets of inflammatory myopathies","volume":"8","author":"Passadore","year":"2009","journal-title":"J Proteome Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2002-0191\u00b0C","article-title":"The antimicrobial activity of the cathelicidin Ll37 is inhibited by f-actin bundles and restored by gelsolin","volume":"28","author":"Weiner","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200409-1185\u00b0C","article-title":"Gelsolin secretion in interleukin-4-Treated bronchial epithelia and in asthmatic airways","volume":"172","author":"Candiano","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/248574","article-title":"Low concentration of S100a8\/9 promotes angiogenesis-related activity of vascular endothelial cells: Bridges among inflammation, angiogenesis, and tumorigenesis","volume":"2012","author":"Li","year":"2012","journal-title":"Mediators Inflammation"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0446","article-title":"Mrp8 and Mrp14 control microtubule reorganization during transendothelial migration of phagocytes","volume":"104","author":"Vogl","year":"2004","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2520","article-title":"Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells","volume":"105","author":"Viemann","year":"2005","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2017.0354","article-title":"The diagnosis and treatment of sj\u00f6gren's syndrome","volume":"114","author":"Stefanski","year":"2017","journal-title":"Deutsches Arzteblatt Int"},{"key":"B55","article-title":"[Screening for serum specific biomarkers in patients with primary sj\u00f6gren's syndrome and interstitial lung disease using proteomic fingerprint techniques]","volume":"44","author":"Li","year":"2012","journal-title":"Beijing da xue xue bao Yi xue ban = J Peking Univ Health Sci"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24367","article-title":"Biomarkers of connective tissue disease-associated interstitial lung disease in bronchoalveolar lavage fluid: A label-free mass spectrometry-based relative quantification study","volume":"36","author":"Ye","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061579","article-title":"Cadm1 is a key receptor mediating human mast cell adhesion to human lung fibroblasts and airway smooth muscle cells","volume":"8","author":"Moiseeva","year":"2013","journal-title":"PloS One"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.033043","article-title":"Sil1, the endoplasmic-Reticulum-Localized bip Co-chaperone, plays a crucial role in maintaining skeletal muscle proteostasis and physiology","volume":"11","author":"Ichhaporia","year":"2018","journal-title":"Dis Models Mech"},{"key":"B59","doi-asserted-by":"publisher","first-page":"ar120","DOI":"10.1091\/mbc.E22-06-0233","article-title":"A small-molecule inhibitor and degrader of the Rnf5 ubiquitin ligase","volume":"33","author":"Ruan","year":"2022","journal-title":"Mol Biol Cell"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2022-0252\u00b0C","article-title":"Epithelial er stress enhances the risk of Muc5b associated lung fibrosis","volume":"68","author":"Dobrinskikh","year":"2022","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2022.06.008","article-title":"Chemically modified recombinant human sulfamidase (Sobi003) in mucopolysaccharidosis iiia patients: Results from an open, non-controlled, multicenter study","volume":"136","author":"Harmatz","year":"2022","journal-title":"Mol Genet Metab"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126400","article-title":"Targeting of glycosaminoglycans in genetic and inflammatory airway disease","volume":"23","author":"Caird","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02256","article-title":"Genetic association of pulmonary surfactant protein genes, Sftpa1, Sftpa2, sftpb, sftpc, and sftpd with cystic fibrosis","volume":"9","author":"Lin","year":"2018","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080633","article-title":"Surfactant protein d and kl-6 as serum biomarkers of interstitial lung disease in patients with scleroderma","volume":"36","author":"Hant","year":"2009","journal-title":"J Rheumatol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232978","article-title":"Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease","volume":"15","author":"Avouac","year":"2020","journal-title":"PloS One"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm-conference.2020.201.1_MeetingAbstracts.A1093","article-title":"Surfactant protein d is associated with 3-month mortality of anti-Mda5 antibody-interstitial lung disease","volume":"38","author":"Lyu","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/apm.12785","article-title":"Localization of surfactant protein-d in the rheumatoid synovial membrane","volume":"126","author":"Christensen","year":"2018","journal-title":"APMIS Acta pathologica microbiologica immunologica Scandinavica"},{"key":"B68","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/s2213-2600(21)00503-8","article-title":"Proteomic biomarkers of progressive fibrosing interstitial lung disease: A multicenter cohort analysis","volume":"10","author":"Bowman","year":"2022","journal-title":"Lancet Respir Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.AC119.012066","article-title":"Kelch-like protein 42 is a profibrotic ubiquitin E3 ligase involved in systemic sclerosis","volume":"295","author":"Lear","year":"2020","journal-title":"J Biol Chem"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1146904\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T01:30:46Z","timestamp":1680053446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1146904\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":69,"alternative-id":["10.3389\/fimmu.2023.1146904"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1146904","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"article-number":"1146904"}}